(Circulation. 2000;102:1454.)
© 2000 American Heart Association, Inc.
Basic Science Reports |
Electrical, Morphological, and Ultrastructural Remodeling and Reverse Remodeling in a Canine Model of Chronic Atrial Fibrillation
From the Cardiovascular Division, Department of Internal Medicine and Department of Cell Biology, University of Virginia Health System, Charlottesville, Va.
Correspondence to David E. Haines, MD, Box 158, Cardiovascular Division, University of Virginia Health System, Charlottesville, VA 22908. E-mail dhaines{at}virginia.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—In patients with recurrent persistent atrial fibrillation (AF), vulnerability to AF persists indefinitely despite presumed completion of reverse electrical remodeling within days of return to normal sinus rhythm. Atrial electrical and anatomic remodeling and reverse remodeling were studied in a canine model of chronic AF.
Methods and Results—Chronic AF was induced in 8 dogs by creating moderate mitral regurgitation and rapidly pacing the right atrium at 640 bpm for >8 weeks. Measurements performed at baseline, after establishment of chronic AF, and then at 4 hours and again at 7 to 14 days after cardioversion to sinus rhythm included atrial effective refractory periods, AF cycle lengths, left atrial dimensions, premature atrial contraction (PAC) frequency, and atrial vulnerability to atrial extrastimuli. After establishing chronic AF, atrial effective refractory period shortening, increases in spontaneous PAC frequency, increases in left atrial size with loss of contractility, and multiple ultrastructural abnormalities were demonstrated. Complete reverse electrical remodeling and decreases in PACs were observed after 7 to 14 days of sinus rhythm, but there was no resolution of anatomic and ultrastructural abnormalities. Occurrence of spontaneous AF paralleled PAC frequency, but vulnerability to AF induction persisted (75% immediately after conversion versus 63% at 4 hours and 50% at 7 to 14 days) despite reverse electrical remodeling.
Conclusions—After conversion from chronic AF to sinus rhythm in this canine model, electrical remodeling occurs rapidly. However, gross and ultrastructural anatomic changes persist, as does vulnerability to induced AF. Vulnerability to AF initiation 7 to 14 days after cardioversion is more dependent on persisting structural abnormalities than on electrophysiological abnormalities.
Key Words: arrhythmia • atrial fibrillation • remodeling • atrium
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Atrial fibrillation (AF) is a common disease that is characterized by multiple wavelets of reentry that are both functionally and anatomically determined.1 2 As AF persists, it often develops into chronic AF. Studies have shown that the atria undergo electrophysiological changes, or electrical remodeling, during AF, which promotes the continuation of AF. These changes include shortening of the AF cycle lengths (AFCLs) and shortening of the atrial effective refractory period (AERP).3 4 5 6 7 8 9 After restoration of sinus rhythm, recovery of atrial mechanical function is delayed depending on the duration of AF,10 and the vulnerability to AF persists, with the highest risk of AF recurrence occurring within the first week after cardioversion.11 12 13 14 After long periods of AF, it has been shown that the atrial tissue develops structural abnormalities, which can be observed on gross examination (evidenced by atrial enlargement) and histologically (on the ultrastructural level).4 15 It is not clear what role the persistent structural abnormalities seen after cardioversion play in the recovery of atrial function and in the spontaneous recurrence of AF. The purpose of the present study was to develop an animal model of chronic AF and to assess the relative contributions of electrical and morphological remodeling to AF propagation and vulnerability.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Establishment of Chronic AF
Chronic AF was established with the combination of rapid atrial pacing and creation of moderate mitral regurgitation as previously described.16 Catheters were introduced into the left and right heart of female mongrel dogs via femoral venous and arterial sheaths. Baseline hemodynamic measurements were recorded. A 7F steerable catheter with a stiff 2-mm wire hook at its terminus was placed in the left ventricle and manipulated until mitral chordae tendineae were ensnared and then avulsed. This procedure was repeated until the mean wedge pressure increased 5 mm Hg with associated V waves on the wedge pressure tracing and there was an audible mitral regurgitation murmur. The catheters were removed, and the wounds were repaired.
An active-fixation atrial J permanent pacemaker lead (Telectronics Pacing Systems, Inc, or Medtronic Inc) was placed in the right atrial appendage by a jugular venous approach. The lead was connected to a specially modified Telectronics or Medtronics implantable pulse generator, and appropriate atrial pacing was confirmed. The pacemakers were programmed to a rate of 640 bpm (Telectronics) or 400 bpm (Medtronics) and an output of 2 to 3 times atrial diastolic threshold. After 6 weeks and weekly thereafter, the pacemakers were reprogrammed to low rates and to subthreshold outputs. After 24 hours without pacing, a 6-lead surface ECG was obtained to verify the presence of AF. If AF was present, a 24-hour ambulatory ECG recording was obtained (SpaceLabs Inc) to confirm that the rhythm was sustained.
Electrophysiological Testing
A roving standard ablation catheter (EP Technologies) was
introduced to 5 sites in the atria: right atrial appendage, anterior
right atrium, posterior right atrium, anterior left atrium, and
posterior left atrium. AERP was determined at each of the 5 atrial
locations by pacing the atria at twice diastolic threshold
with an 8-beat drive train at 350 ms, followed by a single
extrastimulus. The atria were considered vulnerable to fibrillation if
the arrhythmia occurred spontaneously or was easily induced.
Spontaneous AF was defined as AF that occurred spontaneously and
required cardioversion for termination. Easily induced AF was defined
as AF induced by a single atrial extrastimulus that required a
cardioversion to terminate. Only episodes of AF lasting >5 minutes
requiring cardioversion were recorded. After each AERP was
determined, AF was briefly induced with burst pacing to determine AFCL
at each location. AFCL was defined as the mean of 25 consecutive
activation intervals.
All cardioversions were performed with 3-ms biphasic intra-atrial shocks. After a successful cardioversion, the rhythm was observed, and the frequency of premature atrial contractions (PACs) was recorded.
Intracardiac Ultrasound
A 6F 12.5-MHz intravenous ultrasound catheter
(Hewlett-Packard) was introduced into the left atrial appendage of the
dogs through the transseptal sheath. Imaging of the left atrium was
performed in sinus rhythm (with use of the Hewlett-Packard SONOS
intravascular ultrasound system) as the catheter was withdrawn through
the sheath at 0.5-cm intervals. Images were recorded on videotape
for offline analysis.
An estimate of left atrial volume and surface area was calculated by planimetry of the intravascular ultrasound images recorded at 0.5-cm intervals. At each interval, the maximum diastolic and minimum systolic area along with the diameter were planimetered. The left atrial volume was calculated by an Euler approximation of the integration of the areas multiplied by the pullback distance. An atrial ejection fraction was calculated by the percent volume differences between atrial diastole and systole divided by diastolic volume.
Experimental Protocol
Pre-AF Measurements
During the pacemaker implant procedure, before initiation of
pacing, baseline electrophysiological
testing and an intracardiac ultrasound were performed. An additional 2
normal dogs underwent baseline
electrophysiological testing and
intracardiac ultrasound and were then euthanized as control animals for
pathological examination.
After Establishment of Chronic AF
All of the dogs underwent comprehensive testing. Cardioversion
was performed in each animal after ongoing AF was observed for a
minimum of 60 minutes. Before cardioversion, a roving standard ablation
catheter was introduced to 5 sites in the atria: right atrial
appendage, anterior right atrium, posterior right atrium, anterior left
atrium, and posterior left atrium. AF was recorded at each of these
sites for regional AFCL determination. After the initial AF
recordings were obtained, atrial defibrillation was
accomplished. After cardioversion,
electrophysiological testing for AERP and
AF vulnerability assessment and an intracardiac ultrasound were
performed.
After Restoration of Sinus Rhythm
The dogs were observed for a minimum of 4 hours. Dogs
experiencing episodes of spontaneous AF in this interval were
immediately subjected to cardioversion. At the end of the 4-hour
observation period, repeat
electrophysiological testing and
intracardiac ultrasound were performed. AF was briefly reinitiated with
rapid pacing, and the AFCL was measured at the 5 atrial
recording sites. The animal was subjected to cardioversion and
returned to the vivarium in sinus rhythm for observation.
Follow-Up Testing
After a 7- to 14-day period of sinus rhythm, a 24-hour
ambulatory ECG was repeated with use of a Holter monitor.
Electrophysiological testing and intracardiac
ultrasound measurements were again performed. AF was initiated with
rapid pacing, and the regional AFCLs were recorded. After these
measurements, a thoracotomy was performed.
Pathology
At the completion of the protocol, the beating heart was rapidly
extracted, and a small portion of the right atrial appendage, right
atrial free wall, left atrial appendage, and posterior left atria was
excised and fixed for pathological analysis. Microscopic
analysis was performed on 2 normal dogs, 2 dogs with chronic
AF, and 4 dogs after 7 to 14 days of recovery. The tissue was
immediately minced to 
1 mm3 in size in a
room temperature solution containing 4.0%
paraformaldehyde and 2.5%
glutaraldehyde in 0.1 mol/L phosphate buffer at pH 7.4.
After overnight fixation (4°C), the samples were equilibrated to
24°C, washed in 0.1 mol/L phosphate buffer, postfixed for 1 hour in
2.0% osmium tetroxide, dehydrated in acetone, embedded in EPOX 812
(Ernest F. Fullam, Inc), and polymerized for 48 hours at
60°C.
Light Microscopy
After polymerization, thin sections (0.5 mm) were cut from
2 tissue blocks representing 2 different locations within
each atrial region with the use of glass knives and a Reichert
Ultracut-E microtome. Sections were collected on glass slides, stained
with toluidine blue, and examined with a conventional compound
microscope to determine the suitability of the tissue areas for
subsequent ultrathin sectioning and light level morphometry.
Light Level Morphometry
Digital images (512x512 pixels) were obtained from the thin
sections from each block with a x63 (numerical aperture 1.4) Zeiss
objective and a Zeiss LSM 410 laser scanning confocal microscope. By
use of a linear measurement program embedded in the Zeiss LSM 410
software (release 3.98), 10 measurements (in microns) of myocyte
diameters were made on the digitized images from each tissue block
(resulting in 20 myocyte diameter measurements per atrial region). For
each measurement, the widest aspect of the myocyte visible in the image
was selected. These measurements were averaged for reporting of the
mean diameters for myocytes in control and experimental dog atria.
Electron Microscopy
Ultrathin sections (70 to 80 nm) were cut with a diamond knife
and ultramicrotome. The sections were collected on 200 mesh
copper grids (Ernest F. Fullam, Inc), contrast-stained with uranyl
acetate (50% in acetone) and lead citrate,17 and examined
in a JEOL 100-CX transmission electron microscope. Tissue in a
1.5-mm2 area was visually evaluated and given a
score from 1 to 4 based on its degree of abnormality, with 1 being
normal and 4 being highly abnormal.
Data Analysis
Electrophysiological data and clinical data
were stored in a master computer file. Statistical analysis was
conducted by use of RS/1 (BBN Software Inc). Continuous data were
expressed as mean±1 SD. Paired comparisons among conditions were
performed with 2-tailed paired Student t tests. Comparisons
of continuous variables under each condition were performed by
single-factor ANOVA. Statistical significance was defined as
P<0.05.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Baseline measurements were obtained in 12 dogs with a mean weight of 26±3.4 kg. Ten dogs continued with the induction of AF by rapid pacing and chronic testing. Eight dogs underwent testing at the follow-up study. The animals underwent high-rate atrial pacing for 115±61 days (median±quartile range) before achieving chronic AF. All animals that underwent the mitral avulsion and pacing protocol demonstrated sustained AF during the entire 24-hour period of ambulatory ECG monitoring before subsequent testing. Electrical conversion to sinus rhythm was successful in all dogs with persistent AF.
Intracardiac Ultrasound
A characteristic finding in dogs with induced persistent AF was an
increase in left atrial size and a decrease in left atrial ejection
fraction (Figure 1
). There was a
significant increase in left atrial end-diastolic volume
and a decrease in left atrial ejection fraction between measurements at
baseline and those after establishment of persistent AF
(P<0.04). These changes persisted at the follow-up study
despite cardioversion to sinus rhythm 7 to 14 days earlier.
|
Electrophysiological Analysis
The mean AERP values for the 5 individual measurement sites for
each time period tested are shown in Figure 2. After establishment of persistent AF,
the mean AERP for all sites was 106 ms (25%) shorter than the pre-AF
values (P<0.0001). No significant change in the mean
multisite AERP was observed after 4 hours of sinus rhythm, but after
maintaining sinus rhythm for 7 to 14 days, the AERP returned to pre-AF
values (139 versus 141 ms, respectively). No difference in the
magnitude or time course of atrial electrical remodeling and reverse
electrical remodeling was seen among the 5 mapped sites, except for
higher AERP values after 4 hours of sinus rhythm at the anterior right
atrial sites (P=0.05).
|
Figure 3 shows that the mean AFCL
decreased from 125 ms at baseline to 113 ms in chronic AF
(P=0.001) and returned to baseline values over time after
restoration of sinus rhythm. A significant prolongation of AFCL was
observed after just 4 hours of sinus rhythm in the absence of a
prolongation of the AERP at the 5 sites measured, indicating that the
time course of reverse electrical remodeling for the functional
refractory period may be shorter than that for the AERP. The time
course and magnitude of observed AFCL changes were similar among the 5
mapped sites.
|
Immediately after cardioversion from chronic AF, spontaneous sustained
AF recurred in 6 of 8 dogs. After maintaining sinus rhythm for 4 hours,
only 1 of 8 dogs had spontaneous AF, and after 7 to 14 days of sinus
rhythm, no animal had spontaneous AF during the follow-up procedure. In
contrast, AF could be easily induced with single extrastimuli in 5 of 8
dogs immediately after cardioversion from chronic AF, in 5 of 8 dogs 4
hours after cardioversion, and in 4 of 8 dogs after 7 to 14 days of
sinus rhythm (Figure 4). In comparison,
normal dogs demonstrated neither spontaneous episodes of AF nor AF
induction with single atrial extrastimuli. After cardioversion from
persistent AF, the PAC frequency was 4±3 per minute, decreasing to
1±1 per minute after 4 hours of sinus rhythm (P=0.005).
There were no PACs observed at the follow-up procedure (Figure 4).
|
Pathological Examination
Gross Analysis
No pericardial inflammation, effusion, or hemorrhage was
noted in any dog. The chronic AF group demonstrated a significant
increase in left atrial size in all dogs. All dogs had small septal
defects from the transseptal punctures and fibrosis in the right atrial
appendage at the pacer lead implant site. Within the control group, the
heart and intracardiac structures appeared normal.
Electron Microscopy
Tissue from normal dogs (Figure 5A) was compared with tissue from dogs
with chronic AF (Figure 5B) and with dogs that had completed the
7- to 14-day follow-up period of sinus rhythm after cardioversion from
chronic AF (Figure 5C). The semiquantitative analysis of
observations from these specimens is presented in the
Table. Several ultrastructural
abnormalities were observed in the samples from animals with persistent
AF. In both the right and left atria, the intercalated disks were
disrupted in some areas, and the sarcomeres were at various stages of
contraction. There was increased space surrounding the myofibrils
(previously shown to contain large accumulations of
glycogen15 ). The mitochondria were greatly increased in
number and size, and the sarcoplasmic reticulum was partially destroyed
and indistinct. The nuclei appeared active (euchromatic). Although
these abnormalities were seen in both the left and right atria, the
tissue from the right atrium displayed significantly more abnormalities
than did the tissue from the left atrium. Notably, there was no
resolution of any of these findings after restoration of sinus rhythm
for 7 days and completion of reverse electrical remodeling.
|
|
Light Microscopy
Three hundred twenty randomly selected atrial myocytes were
examined and measured. The atrial myocytes from control dogs revealed a
normal composition of sarcomeres distributed throughout the cell, and
the intercellular space also appeared normal (Figure 6A). In contrast, myocytes from the
chronic AF dogs (Figure 6B) and the follow-up dogs (Figure 6C) were smaller in diameter than the myocytes from normal dogs.
The myocytes measured 17.0±3.3 µm in chronic AF dogs versus
18.8±3.5 µm in normal dogs (P=0.001) and
16.3±3.9 µm in follow-up dogs versus 18.8±3.5 µm in
normal dogs (P<0.0001). The light microscopic
analysis also showed a loss of some contractile elements,
particularly around the nucleus. In addition, the intercellular space
was hyperexpanded in most samples from the chronic AF dogs and
follow-up dogs. No inflammatory cells were present.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The present study examined the electrophysiological and histological natural history of remodeling and reverse remodeling in a canine model of persistent AF that combined mitral regurgitation and high-rate atrial pacing. As anticipated, shortened AERPs and AFCLs consistent with electrical remodeling were observed after persistent AF was achieved. Evidence of reverse electrical remodeling was seen as early as 4 hours after cardioversion with an increase in the AFCLs, but AERPs did not normalize until later. The right atrium appeared to begin recovery sooner than did the left atrium, as evidenced by the AERP and the AFCL data after 4 hours of sinus rhythm. Reverse electrical remodeling for all regions was complete at the follow-up study 7 to 14 days after cardioversion. However, despite the restoration of sinus rhythm, marked anatomic abnormalities persisted through the time of the follow-up study, possibly accounting for the decreased contractile function of the atria. Thus, although the atria showed evidence of reverse electrical remodeling, there was no evidence of concomitant reverse anatomic remodeling with restoration of sinus rhythm.
With restoration of sinus rhythm, the propensity for spontaneous recurrence of AF diminished over time and was correlated with a decrease in the frequency of PACs observed. However, the animals remained vulnerable to AF initiation with single atrial extrastimuli. Even though restoration of normal atrial refractoriness should have been protective against AF propagation, the structural abnormalities of the atria, especially their increased size, likely accounted for their continued vulnerability to programmed electrical stimulation. Therefore, the high prevalence of spontaneous recurrence of AF early after cardioversion in this model is likely to be due to a combination of both increased ectopic activity and the propensity for reentrant AF wavelet propagation.
Previous Research
Animal Models of AF Remodeling
Several animal models of chronic sustained AF have been developed
to assess the utility of potential therapies for AF and to further
characterize the arrhythmia.4 8 18 In a model of
pacing-induced (1- to 3-week) AF in instrumented goats,3
AERP and AFCL decreased, and vulnerability to induced AF increased
significantly. The reverse electrical remodeling of the atrial tissue
was almost complete by 1 week of sustained sinus rhythm and complete
after 2 weeks, with the AERPs, AFCLs, and inducibility of AF returning
to levels comparable to baseline measurements.3 Another
study5 examined the acute time course of atrial electrical
remodeling with a protocol using 7 hours of rapid atrial pacing.
Shortening of AERP began within 30 minutes of the onset of pacing, and
reverse electrical remodeling was observed in a similar time period.
The rapid time course of changes in refractoriness in that study
suggest that these changes were likely due to neurohumoral changes
rather than changes in the properties of the atrial
myocytes.5 Two studies6 7 monitored the
atrial electrophysiological changes after
restoration of sinus rhythm in dogs that had been conditioned with 2 to
8 weeks of rapid atrial pacing. In follow-up, some AERP shortening
persisted up to 1 week after return to sinus rhythm, and animals had
persisting vulnerability to AF induction.6 7
The AF model presented in the present study showed electrophysiological remodeling and reverse electrophysiological remodeling similar to those previously described. Complete reverse electrical remodeling was not observed until >4 hours after restoration of sinus rhythm. With increasing time in sinus rhythm, both the prevalence of spontaneous AF and PAC frequency decreased in a parallel fashion. However, despite complete normalization of the AERP, the atria remained vulnerable to AF induction. Thus, it would appear that vulnerability to induced AF remains for 7 to 14 days after sinus rhythm conversion in this model, perhaps because of the persisting left atrial enlargement and cellular abnormalities. But the propensity for spontaneous AF decreases as the prevalence of spontaneous triggers for initiation decreases.
Structural Changes
Electron microscopic analysis of atrial structural changes
has been studied in 2 models of chronic AF.4 15
Ultrastructural changes of atrial myocytes observed in those models and
confirmed in the present study included enlarged nuclei with
dispersed chromatin, an increase in number and size of the
mitochondria, and disruption of the sarcoplasmic reticulum. Also
observed were disintegration of contractile structures and an increase
in glycogen in the myolytic space. Morphometric analysis
reported by Ausma et al15 showed slight enlargement of
myocytes after establishing AF with rapid atrial pacing in goats. In
contrast, some myocytes were smaller and appeared hypercontracted in
the present study. This may be due to a difference in species
tested or methodology for achieving sustained AF. Importantly, the
present data demonstrate that despite complete reverse
electrophysiological remodeling at 7 to 14
days after conversion to sinus rhythm, no corresponding reverse
remodeling of the cellular ultrastructure was observed.
Atrial Function
Studies of patients undergoing cardioversion for persisting AF
have shown that recovery of atrial mechanical function after
restoration of sinus rhythm is delayed and that the time of recovery of
mechanical function is dependent on the duration of AF before
cardioversion.10 19 The present animal model is
consistent with clinical observations in that the atrial
function was markedly depressed after establishment of chronic AF and
these changes persisted for at least 1 week.
Study Limitations
The model chosen included a combination of mitral
regurgitation and rapid atrial pacing to emulate the
clinical syndrome of AF in the setting of left atrial hypertension.
Thus, it was not possible to discern the relative contributions of the
2 interventions to the electrophysiological
and structural/functional changes observed. The follow-up time period
of this study was limited to 7 to 14 days. Longer follow-up time
periods could be used to identify the time period for the return
of atrial function and to determine whether any
reverse structural remodeling occurs.
Conclusions
The present study introduced a canine model of chronic
AF with mitral regurgitation that demonstrated both
electrical remodeling and reverse electrical remodeling. It was shown
that reverse electrical remodeling is complete 7 to 14 days after
cardioversion. The left atrium remained enlarged, and atrial function
was depressed 7 to 14 days after cardioversion. The occurrence of
spontaneous AF decreased with reverse electrical remodeling, but the
vulnerability to easily induced AF persisted in the setting of complete
reverse electrical remodeling and continued anatomic abnormalities.
This suggests that an atrial myopathy in response to chronic AF is the
dominant factor in the recurrence of AF, not electrical
remodeling.
|
Acknowledgments |
|---|
This study was supported in part by a grant from the American Heart Association, Mid-Atlantic Consortium.
Received December 28, 1999; revision received April 14, 2000; accepted April 19, 2000.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Moe GK, Rheinboldt WC, Abildskov JA. A computer model of atrial fibrillation. Am Heart J. 1964;67:200–220.[Medline] [Order article via Infotrieve]
2. Allessie MA, Rensma PL, Brugada J, et al. Pathophysiology of atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders; 1990:548–559.
3.
Wijffels MC, Kirchhof CJ, Dorland R, et al. Atrial
fibrillation begets atrial fibrillation: a study in awake chronically
instrumented goats. Circulation. 1995;92:1954–1968.
4.
Morillo CA, Klein GJ, Jones DL, et al. Chronic rapid
atrial pacing: structural, functional, and
electrophysiological characteristics of a
new model of sustained atrial fibrillation. Circulation. 1995;91:1588–1595.
5.
Goette A, Honeycutt C, Langberg JJ. Electrical
remodeling in atrial fibrillation, time course and mechanisms.
Circulation. 1996;94:2968–2974.
6.
Lee SH, Lin FY, Yu WC, et al. Regional differences in
the recovery course of tachycardia-induced changes of
atrial electrophysiological properties.
Circulation. 1999;99:1255–1264.
7.
Elvan A, Wylie K, Zipes DP. Pacing-induced chronic
atrial fibrillation impairs sinus node function in dogs:
electrophysiological remodeling.
Circulation. 1996;94:2953–2960.
8.
Gaspo R, Bosch RF, Talajic M, et al. Functional
mechanisms underlying tachycardia-induced sustained atrial
fibrillation in a chronic dog model. Circulation. 1997;96:4027–4035.
9.
Li D, Fareh S, Leung TK, et al. Promotion of atrial
fibrillation by heart failure in dogs: atrial remodeling of a different
sort. Circulation. 1999;100:87–95.
10. Manning WJ, Silverman DI, Katz SE, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol. 1994;23:1535–1540.[Abstract]
11. Van Gelder IC, Crijns JH, Van Gilst WH, et al. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol. 1991;68:41–46.[Medline] [Order article via Infotrieve]
12. Reimold SC, Cantillon CO, Friedman PL, et al. Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. Am J Cardiol. 1993;71:558–563.[Medline] [Order article via Infotrieve]
13. Crijns HJGM, Gosselink ATM, Lie KI, for the PRODIS Study Group. Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. Cardiovasc Drugs Ther. 1996;10:145–152.[Medline] [Order article via Infotrieve]
14.
Tieleman RG, VanGelder IC, Crijns HJGM, et al. Early
recurrences of atrial fibrillation after electrical
cardioversion: a result of fibrillation-induced electrical remodeling
of the atria? J Am Coll Cardiol. 1998;31:167–173.
15.
Ausma J, Wijffels M, Thone F, et al. Structural changes
of atrial myocardium due to sustained atrial fibrillation
in the goat. Circulation. 1997;96:3157–3163.
16.
Mitchell MA, McRury ID, Haines DE. Linear atrial
ablations in a canine model of chronic atrial fibrillation:
morphological and electrophysiological
observations. Circulation. 1998;97:1176–1185.
17.
Venable JH, Coggeshall R. A simplified lead citrate
stain for electron microscopy. J Cell Biol. 1965;25:407–408.
18.
Yue L, Feng J, Gaspo R, et al. Ionic remodeling
underlying action potential changes in a canine model of atrial
fibrillation. Circ Res. 1997;81:512–525.
19. Van Gelder IC, Crijns HJGM, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol. 1993;72:560–566.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  L. Sornmo, M. Stridh, D. Husser, A. Bollmann, and S. B. Olsson Analysis of atrial fibrillation: from electrocardiogram signal processing to clinical management Phil Trans R Soc A, January 28, 2009; 367(1887): 235 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. P. Beukema, H. T. Sie, A. R. Ramdat Misier, P. P. H.M. Delnoy, H. J.J. Wellens, and A. Elvan Intermediate to Long-Term Results of Radiofrequency Modified Maze Procedure as an Adjunct to Open-Heart Surgery Ann. Thorac. Surg., November 1, 2008; 86(5): 1409 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bollmann, A. Tveit, D. Husser, M. Stridh, L. Sornmo, P. Smith, and S. B. Olsson Fibrillatory rate response to candesartan in persistent atrial fibrillation Europace, October 1, 2008; 10(10): 1138 - 1144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Roberts-Thomson, I. H. Stevenson, P. M. Kistler, H. M. Haqqani, J. C. Goldblatt, P. Sanders, and J. M. Kalman Anatomically Determined Functional Conduction Delay in the Posterior Left Atrium: Relationship to Structural Heart Disease J. Am. Coll. Cardiol., February 26, 2008; 51(8): 856 - 862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Casaclang-Verzosa, B. J. Gersh, and T. S.M. Tsang Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 1 - 11. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Regan, L. Kiss, G. L. Stump, C. J. McIntyre, D. C. Beshore, N. J. Liverton, C. J. Dinsmore, and J. J. Lynch Jr. Atrial Antifibrillatory Effects of Structurally Distinct IKur Blockers 3-[(Dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2H)-one and 2-Phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in Dogs with Underlying Heart Failure J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 322 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Everett IV, E. E. Wilson, S. Verheule, J. M. Guerra, S. Foreman, and J. E. Olgin Structural atrial remodeling alters the substrate and spatiotemporal organization of atrial fibrillation: a comparison in canine models of structural and electrical atrial remodeling Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2911 - H2923. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bollmann, D. Husser, L. Mainardi, F. Lombardi, P. Langley, A. Murray, J. J. Rieta, J. Millet, S. B. Olsson, M. Stridh, et al. Analysis of surface electrocardiograms in atrial fibrillation: techniques, research, and clinical applications. Europace, November 1, 2006; 8(11): 911 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E.W. Hemels, T. Van Noord, H. J.G.M. Crijns, D. J. Van Veldhuisen, N. J.G.M. Veeger, H. A. Bosker, A. C.P. Wiesfeld, M. P. Van den Berg, A. V. Ranchor, and I. C. Van Gelder Verapamil Versus Digoxin and Acute Versus Routine Serial Cardioversion for the Improvement of Rhythm Control for Persistent Atrial Fibrillation J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1001 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 651 - 745. [Full Text] [PDF]
|
|
|
|
|
|
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246. [Full Text] [PDF]
|
|
|
|
 |
|
 V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society Circulation, August 15, 2006; 114(7): e257 - e354. [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Hogue Jr., L. L. Creswell, D. D. Gutterman, and L. A. Fleisher Epidemiology, Mechanisms, and Risks: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery Chest, August 1, 2005; 128(2_suppl): 9S - 16S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Verma, O. M. Wazni, N. F. Marrouche, D. O. Martin, F. Kilicaslan, S. Minor, R. A. Schweikert, W. Saliba, J. Cummings, J. D. Burkhardt, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: An independent predictor of procedural failure J. Am. Coll. Cardiol., January 18, 2005; 45(2): 285 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Deroubaix, T. Folliguet, C. Rucker-Martin, S. Dinanian, C. Boixel, P. Validire, P. Daniel, A. Capderou, and S. N. Hatem Moderate and chronic hemodynamic overload of sheep atria induces reversible cellular electrophysiologic abnormalities and atrial vulnerability J. Am. Coll. Cardiol., November 2, 2004; 44(9): 1918 - 1926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H Madrid, I. M. Marin, C. Escobar Cervantes, E. Bernal Morell, J. Escudero Estevez, G. Moreno, J. Rondon Parajon, Jian Peng, L. Limon, S. Nannini, et al. Prevention of recurrences in patients with lone atrial fibrillation. The dose-dependent effect of angiotensin II receptor blockers Journal of Renin-Angiotensin-Aldosterone System, September 1, 2004; 5(3): 114 - 120. [Abstract] [PDF]
|
|
|
|
|
|
P. L. L'Allier, A. Ducharme, P.-F. Keller, H. Yu, M.-C. Guertin, and J.-C. Tardif Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation J. Am. Coll. Cardiol., July 7, 2004; 44(1): 159 - 164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. H. Everett IV, S. Verheule, E. E. Wilson, S. Foreman, and J. E. Olgin Left atrial dilatation resulting from chronic mitral regurgitation decreases spatiotemporal organization of atrial fibrillation in left atrium Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2452 - H2460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakano, S. Niida, K. Dote, S. Takenaka, H. Hirao, F. Miura, M. Ishida, T. Shingu, T. Sueda, M. Yoshizumi, et al. Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation J. Am. Coll. Cardiol., March 3, 2004; 43(5): 818 - 825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.C. Geller, S. Reek, C. Timmermans, T. Kayser, H.-F. Tse, C. Wolpert, W. Jung, A.J. Camm, C.-P. Lau, H. J.J. Wellens, et al. Treatment of atrial fibrillation with an implantable atrial defibrillator -- long term results Eur. Heart J., December 1, 2003; 24(23): 2083 - 2089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-C. Ueng, T.-P. Tsai, W.-C. Yu, C.-F. Tsai, M.-C. Lin, K.-C. Chan, C.-Y. Chen, D.-J. Wu, C.-S. Lin, and S.-A. Chen Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation: Results of a prospective and controlled study Eur. Heart J., December 1, 2003; 24(23): 2090 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cardin, D. Li, N. Thorin-Trescases, T.-K. Leung, E. Thorin, and S. Nattel Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways Cardiovasc Res, November 1, 2003; 60(2): 315 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kumagai, H. Nakashima, H. Urata, N. Gondo, K. Arakawa, and K. Saku Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation J. Am. Coll. Cardiol., June 18, 2003; 41(12): 2197 - 2204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Gronefeld and S. H. Hohnloser Heart Failure Complicated by Atrial Fibrillation: Mechanistic, Prognostic, and Therapeutic Implications Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2003; 8(2): 107 - 113. [Abstract] [PDF]
|
|
|
|
|
|
S. Verheule, E. Wilson, T. Everett IV, S. Shanbhag, C. Golden, and J. Olgin Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation Circulation, May 27, 2003; 107(20): 2615 - 2622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ausma, H. M.W. van der Velden, M.-H. Lenders, E. P. van Ankeren, H. J. Jongsma, F. C.S. Ramaekers, M. Borgers, and M. A. Allessie Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat Circulation, April 22, 2003; 107(15): 2051 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Morton, P. Sanders, J. K. Vohra, P. B. Sparks, J. G. Morgan, S. J. Spence, L. E. Grigg, and J. M. Kalman Effect of Chronic Right Atrial Stretch on Atrial Electrical Remodeling in Patients With an Atrial Septal Defect Circulation, April 8, 2003; 107(13): 1775 - 1782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Fynn and C. J. Garratt The effectiveness of serial cardioversion therapy for recurrence of atrial fibrillation Eur. Heart J., October 1, 2002; 23(19): 1487 - 1489. [Full Text] [PDF]
|
|
|
|
|
|
A. Goette, M. Arndt, C. Rocken, T. Staack, R. Bechtloff, D. Reinhold, C. Huth, S. Ansorge, H. U. Klein, and U. Lendeckel Calpains and cytokines in fibrillating human atria Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H264 - H272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shinagawa, Y.-F. Shi, J.-C. Tardif, T.-K. Leung, and S. Nattel Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs Circulation, June 4, 2002; 105(22): 2672 - 2678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res, May 1, 2002; 54(2): 230 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kostin, G. Klein, Z. Szalay, S. Hein, E. P Bauer, and J. Schaper Structural correlate of atrial fibrillation in human patients Cardiovasc Res, May 1, 2002; 54(2): 361 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L.J.L Thijssen, H. M.W van der Velden, E. P van Ankeren, J. Ausma, M. A Allessie, M. Borgers, G. J.J.M van Eys, and H. J Jongsma Analysis of altered gene expression during sustained atrial fibrillation in the goat Cardiovasc Res, May 1, 2002; 54(2): 427 - 437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, K. Shinagawa, L. Pang, T. K. Leung, S. Cardin, Z. Wang, and S. Nattel Effects of Angiotensin-Converting Enzyme Inhibition on the Development of the Atrial Fibrillation Substrate in Dogs With Ventricular Tachypacing-Induced Congestive Heart Failure Circulation, November 20, 2001; 104(21): 2608 - 2614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L.J.L. Thijssen, J. Ausma, and M. Borgers Structural remodelling during chronic atrial fibrillation: act of programmed cell survival Cardiovasc Res, October 1, 2001; 52(1): 14 - 24. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||